Business
Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors
Strengthens Leadership Team and Board with additional business development, finance and royalty management expertise SAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced the appointment of Christopher Murphy as Chief Financial Officer and Owen Hughes as a member of its Board of Directors. “We are excited to welcome Chris, who will be fully dedicated
About this update from Anaptysbio, Inc.
[{"type":"image","alt":"AnaptysBio, Inc.","displaySize":"","headline":null,"caption":"AnaptysBio, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":85,"url":"https://media.zenfs.com/en/globenewswire.com/5dd7f30a0ad6f5e52c819b2cf00b5a83"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.iih9fgXNbOAwMH5sv5aNg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExOQ--/https://media.zenfs.com/en/globenewswire.com/5dd7f30a0ad6f5e52c819b2cf00b5a83","width":300,"height":85},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/.iih9fgXNbOAwMH5sv5aNg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExOQ--/https://media.zenfs.com/en/globenewswire.com/5dd7f30a0ad6f5e52c819b2cf00b5a83","width":300,"height":85}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Strengthens Leadership Team and Board with additional business development, finance and royalty management expertise","length":116,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":116,"olType":false},{"type":"text","content":"SAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced the appointment of Christopher Murphy as Chief Financial Officer and Owen Hughes as a member of its Board of Directors.","length":321,"tagName":"p"},{"type":"text","content":"“We are excited to welcome Chris, who will be fully dedicated to Anaptys, and Owen, both of whom deepen our team’s strong mix of expertise across finance, business development, royalty management and strategic transactions,” said Daniel Faga, president and chief executive officer. “We believe these strong additions will continue Anaptys’ focus on protecting and returning the value of our royalty assets to shareholders.”","length":423,"tagName":"p"},{"type":"text","content":"Christopher M. Murphy Appointed Chief Financial Officer","length":55,"tagName":"p"},{"type":"text","content":"Mr. Murphy has extensive experience in business development, corporate strategy and investment banking. He previously served as CFO and CBO of Third Harmonic Bio, where he was instrumental in maximizing shareholder value and returning value to shareholders. Prior to Third Harmonic, he served as a senior leader at Horizon Therapeutics PLC, where he played a key role in the company’s transforma...